| 000 | 01416cam a22003614a 4500 | ||
|---|---|---|---|
| 001 | 593838 | ||
| 003 | OCoLC | ||
| 005 | 20210921175505.0 | ||
| 008 | 040826s2004 enk b 001 0 eng | ||
| 020 | _a9780853695677 | ||
| 020 |
_a9780853695677 : _cNo price |
||
| 020 | _a0853695679 | ||
| 035 | _a(OCoLC)56593838 | ||
| 040 |
_aNLM _cNLM _dUKM _dIXA _dBAKER _dMUQ _dYDXCP _dCGC _dBTCTA |
||
| 042 | _apcc | ||
| 082 | 0 | 4 |
_a615.19 _bHAR |
| 100 | 1 | _aHarman, Robin J. | |
| 245 | 1 | 0 | _aDevelopment and control of medicines and medical devices / |
| 260 |
_aLondon ; _aChicago : _bPharmaceutical Press, _c2004. |
||
| 300 |
_axiii, 258 p. ; _c26 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 520 | 8 | _aThis new title describes the tests and processes undertaken to bring new medicines and medical devices to the market, and the work of the government agencies which ensure products of the highest standard. The text covers the controls to prove quality, safety, and efficacy prior to marketing, and postmarketing pharmacovigilance requirements. | |
| 650 | 0 |
_aDrug development. _932738 |
|
| 650 | 0 |
_aPharmaceutical industry. _92084 |
|
| 902 | _a151118 | ||
| 907 |
_a.b10538306 _bsmmai _c- |
||
| 942 | _n0 | ||
| 948 | _hNO HOLDINGS IN LQI - 68 OTHER HOLDINGS | ||
| 998 |
_b0 _c081106 _dm _ea _g0 |
||
| 999 |
_c50486 _d50486 |
||